[
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts",
    "summary": "We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best dividend leaders to buy. Investors have long been drawn to dividend stocks due to their financial stability […]",
    "url": "https://finnhub.io/api/news?id=673160594b2c7eb87b1b3a235a1c86628391072733028a9be5e082442b9d17ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734792114,
      "headline": "Pfizer Inc. (PFE) Is Among the Best Dividend Leaders to Buy According to Wall Street Analysts",
      "id": 132100590,
      "image": "https://s.yimg.com/ny/api/res/1.2/EpAz_Vcy0hmyqhi5PSK_ZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best dividend leaders to buy. Investors have long been drawn to dividend stocks due to their financial stability […]",
      "url": "https://finnhub.io/api/news?id=673160594b2c7eb87b1b3a235a1c86628391072733028a9be5e082442b9d17ed"
    }
  },
  {
    "ts": null,
    "headline": "The three-year loss for Pfizer (NYSE:PFE) shareholders likely driven by its shrinking earnings",
    "summary": "In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...",
    "url": "https://finnhub.io/api/news?id=104ea6447105274c6972b6e8d90efebd7a5e98a211db966ea2e71688b6e32fc2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734782416,
      "headline": "The three-year loss for Pfizer (NYSE:PFE) shareholders likely driven by its shrinking earnings",
      "id": 132095427,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/8f018d189c2c443014c49845310ae091",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...",
      "url": "https://finnhub.io/api/news?id=104ea6447105274c6972b6e8d90efebd7a5e98a211db966ea2e71688b6e32fc2"
    }
  },
  {
    "ts": null,
    "headline": "The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025",
    "summary": "When things seem too good to be true on Wall Street, they usually are.",
    "url": "https://finnhub.io/api/news?id=9d833a3227a6e3f13440ef76750f2ef7ca185150d84c300325145c6f76aa54cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734775560,
      "headline": "The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025",
      "id": 132091842,
      "image": "https://g.foolcdn.com/editorial/images/801533/stock-chart-crash-invest-broker-tablet-crypto-plunge-bubble-getty.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "When things seem too good to be true on Wall Street, they usually are.",
      "url": "https://finnhub.io/api/news?id=9d833a3227a6e3f13440ef76750f2ef7ca185150d84c300325145c6f76aa54cd"
    }
  },
  {
    "ts": null,
    "headline": "My Top 10 Stocks to Buy for 2025",
    "summary": "Most of these stocks have a solid earnings track record (except for the clinical-stage biotech that doesn't yet generate product revenue).  A key catalyst is unfolding right now: This top artificial intelligence (AI) chip designer is ramping production of its Blackwell architecture, and demand is \"staggering,\" the company has said.  Nvidia's commitment to innovation should keep it ahead of rivals, making the stock looked reasonably priced today at 43x forward earnings estimates.",
    "url": "https://finnhub.io/api/news?id=a8d105624d7dc9b8a3e61a846be3a8c127bb3234d0da9023e8414c9b5e6873e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734771900,
      "headline": "My Top 10 Stocks to Buy for 2025",
      "id": 132090473,
      "image": "https://g.foolcdn.com/editorial/images/801386/gettyimages-1070239362.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Most of these stocks have a solid earnings track record (except for the clinical-stage biotech that doesn't yet generate product revenue).  A key catalyst is unfolding right now: This top artificial intelligence (AI) chip designer is ramping production of its Blackwell architecture, and demand is \"staggering,\" the company has said.  Nvidia's commitment to innovation should keep it ahead of rivals, making the stock looked reasonably priced today at 43x forward earnings estimates.",
      "url": "https://finnhub.io/api/news?id=a8d105624d7dc9b8a3e61a846be3a8c127bb3234d0da9023e8414c9b5e6873e6"
    }
  }
]